KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Retained Earnings: 2018-2024

Historic Retained Earnings for Castle Biosciences (CSTL) over the last 7 years, with Dec 2024 value amounting to -$200.1 million.

  • Castle Biosciences' Retained Earnings fell 5.86% to -$222.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$222.0 million, marking a year-over-year decrease of 5.86%. This contributed to the annual value of -$200.1 million for FY2024, which is 8.36% up from last year.
  • Castle Biosciences' Retained Earnings amounted to -$200.1 million in FY2024, which was up 8.36% from -$218.4 million recorded in FY2023.
  • In the past 5 years, Castle Biosciences' Retained Earnings registered a high of -$62.5 million during FY2020, and its lowest value of -$218.4 million during FY2023.
  • Over the past 3 years, Castle Biosciences' median Retained Earnings value was -$200.1 million (recorded in 2024), while the average stood at -$193.1 million.
  • In the last 5 years, Castle Biosciences' Retained Earnings crashed by 71.60% in 2022 and then rose by 8.36% in 2024.
  • Yearly analysis of 5 years shows Castle Biosciences' Retained Earnings stood at -$62.5 million in 2020, then tumbled by 50.04% to -$93.8 million in 2021, then tumbled by 71.60% to -$160.9 million in 2022, then slumped by 35.71% to -$218.4 million in 2023, then climbed by 8.36% to -$200.1 million in 2024.